• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
april@madhedgefundtrader.com

Not Super By Super Micro

Tech Letter

This is the first blip in quite a while for the chip sector.

It has almost been perfect in the latest leg up in the tech market carried by heavy hitter Nvidia (NVDA).

I don’t think this will have a significant knock-on effect on the prospects of NVDA.

NVDA is an animal of its own and I do believe we will see great earnings and positive forward guidance that could mean the next gasp up in tech stocks. 

Today represents the first black eye for the AI generative movement when short seller Hindenburg research accused Super Micro Computer (SMCI) of “account manipulation.”

There was a three-month investigation and many former insiders were contacted.

Hindenburg research has a pretty good track record calling out tech frauds.

Most of their calls focus on public stocks helmed by predominately Chinese nationals.

SMCI stock crashed 25% on the day, and it is an ominous setup going into Nvidia earnings later today.

Hindenburg said it reviewed various instances that suggested there were ongoing bookkeeping issues within the $35 billion tech firm even after the SEC charged it with "widespread accounting violations" in 2020.

Workers within the company said they faced pressure to meet high sales quotas, even after the company was charged by regulators.

The high quotas incentivized some workers to ship defective products.

Some of Super Micro's partners appeared to do little business outside their relationship with Super Micro. Ablecom, one such partner, exported 99.8% of its product in the US to Super Micro, while Compuware, another partner, exported 99.7% of its product to Super Micro.

Hindenburg also said Super Micro also ramped up exports to Russia after Moscow invaded Ukraine, which violated US sanctions.

Hindenburg highlighted quality concerns among Super Micro's customers, some of whom have turned to alternative suppliers. Tesla and CoreWeave, two of Super Micro's major customers, have inked high-profile deals with Dell over the past year because they found SMCIs products inferior.

The tsunami of bad news for SMCI means it is time to avoid the stock.

The company faces a torrent of accounting, governance, and compliance issues and offers an inferior product and service now being eroded away by more impactful competition.

The accusations are quite structural and investors won’t be able to just turn a blind eye to all of this.

SMCI delayed reporting their earnings at the last second which tells an investor audience that much of the accusation has some truth to it.

There is a lot to solve internally and I don’t think investors should swoop in and buy the dip just yet.

If there is a bounce, it most likely will be a dead cat bounce.

Although not an existential problem, this short seller report will set back SMCI 5 years and that is a long time in the world of tech.

Readers should avoid this chip stock and head to higher ground.

There is a possibility that this is just the tip of the iceberg and the core could find out to be a lot more rotten than first thought.

Readers will be better off sticking with the likes of Nvidia, Broadcom, AMD, and Micron.

 

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-08-28 14:02:392024-08-28 15:09:47Not Super By Super Micro
april@madhedgefundtrader.com

August 28, 2024 - Quote of the Day

Tech Letter

“If you can't tolerate critics, don't do anything new or interesting.” – Said Amazon Co-Founder Jeff Bezos

 

https://www.madhedgefundtrader.com/wp-content/uploads/2018/05/Jeff-Bezos-quote-of-the-day.jpg 256 256 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-08-28 14:00:482024-08-29 13:36:22August 28, 2024 - Quote of the Day
april@madhedgefundtrader.com

August 28, 2024

Jacque's Post

 

(THERE MAY BE LIGHT AT THE END OF THE TUNNEL AFTER A LONG “WINTER” FOR MINERS IN AUSTRALIA)

August 28, 2024

 

Hello everyone,

Some good news from BHP

 

 

BHP has achieved a multi-billion-dollar profit, and it was all about China. 

BHP shipped most of its iron ore off to China, but a hefty amount also went to Japan.

China’s insatiable demand for iron ore (and coal) drives prices, and BHP’s profits – last year, this year, and out into the 2030s.

Because of this trade, Canberra receives a sizeable tax from BHP as do the states from royalties.  In the 2023-24 year, a not too shabby $US11bn ($16bn) changed hands.

The future of BHP, and indeed, Australia, remains all about China.

Despite China’s structural problems, BHP does not see Chinese demand for iron ore slipping, or even dramatically plunging, in the future.

And to counter all the negative narratives about BHP’s health in relationship to its main trading partner, BHP is actually planning to increase its production out of the Pilbara, from 260 million tonnes a year to 305 million tonnes; and has longer-term plans to go to 330m tonnes.

BHP is also increasingly about copper; and that is also mostly about China.

Worthy of note is the fact that 50% of copper produced in the world is consumed by China, as was pointed out on Tuesday by BHP’s CFO, Vandita Pant.

Copper contributed just under $US9bn, or nearly one-third of the group’s gross profit.

Interestingly, BHP’s CEO has stated that he expects a turnaround in China’s property sector in the year ahead. 

 

BHP WEEKLY CHART

 

QI CORNER

 

 

SOMETHING TO THINK ABOUT

Identity Theft is on the Rise

 

To protect your data, experts say freezing your credit should be a priority.

“Freezing your credit is the single most important thing you can do when you get a data breach notice,” James E. Lee, chief operating officer at the Identity Theft Resource Centre, a nonprofit working to minimize the risk of identity theft.

Freezing your credit is free and takes just minutes.

A credit freeze will limit access to your credit report and prevent the opening of new accounts in your name, either by you or other parties.

A credit freeze will last until you remove it.

To freeze your credit, you need to complete the process at all three major credit reporting agencies – Equifax, Experian, and TransUnion.  Set up free online accounts with each agency.  You can request a freeze by phone, mail, or online.

Monitor your free credit report to check the latest activity.

Other tips to keep your personal data secure.

Use complex and unique passwords for each website.

Use two-factor authentication or encryption.

Remove personal information on social media that can be used by identity thieves.

Set up alerts on accounts which will keep you up to date on the latest activity.

 

 

 

Cheers,

Jacquie

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-08-28 12:00:552024-08-28 13:26:51August 28, 2024
april@madhedgefundtrader.com

Trade Alert - (MU) August 28, 2024 - STOP LOSS - SELL

Tech Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-08-28 11:01:432024-08-28 11:01:43Trade Alert - (MU) August 28, 2024 - STOP LOSS - SELL
april@madhedgefundtrader.com

August 28, 2024

Diary, Newsletter, Summary

Global Market Comments
August 28, 2024
Fiat Lux

 

Featured Trade:

(THE GOVERNMENT’S WAR ON MONEY)
(TESTIMONIAL)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-08-28 09:06:542024-08-28 10:34:28August 28, 2024
april@madhedgefundtrader.com

August 28, 2024 - Quote of the Day

Diary, Newsletter, Quote of the Day

“This turning 80 thing is not all it’s cracked up to be,” said Rolling Stones legend Mick Jagger.

 

https://www.madhedgefundtrader.com/wp-content/uploads/2024/08/Mick-Jagger.png 432 346 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-08-28 09:00:552024-08-28 10:33:15August 28, 2024 - Quote of the Day
april@madhedgefundtrader.com

August 27, 2024

Biotech Letter

Mad Hedge Biotech and Healthcare Letter
August 27, 2024
Fiat Lux

 

Featured Trade:

(NOT ALL THAT GLITTERS IS LILLY)

(JNJ), (LLY), (CRSP), (ISRG)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-08-27 12:02:482024-08-27 12:42:04August 27, 2024
april@madhedgefundtrader.com

Not All That Glitters Is Lily

Biotech Letter

I've been so busy chasing after Eli Lilly (LLY) and its trillion-dollar dreams that I nearly overlooked a gem in the making.

While everyone's obsessing over LLY's march towards that coveted $1 trillion market cap, there's another pharma giant that's been quietly chugging along, building value like it has for over a century.

I'm talking about Johnson & Johnson (JNJ). You know, that little company that's only been around for 138 years.

I understand that JNJ isn’t as exciting as the likes of Crispr Therapeutics (CRSP) with their fancy gene editing therapies, or Intuitive Surgical (ISRG) with their robotic surgeons, but, let me tell you, sometimes boring is beautiful – especially when it comes with a 3% dividend yield and a rock-solid business model.

Let's break it down, shall we?

First off, JNJ isn't sitting on its laurels. Just last week, they dropped $1.7 billion to snatch up a private heart-device company. That's not chump change, even for a behemoth like JNJ.

And speaking of big moves, the FDA just gave them the green light for a chemotherapy-free lung cancer treatment.

We're talking about Rybrevant plus Lazcluze, which showed a 30% reduction in the risk of disease progression or death compared to AstraZeneca's (AZN) offering.

That's not just incremental progress – that's potentially life-changing stuff for patients.

But they’re not stopping there. They're also shelling out $600 million upfront (with potential milestone payments up to $1.1 billion) for V-Wave, a company making shunts for heart failure patients.

This deal's expected to close before the year's out, beefing up JNJ's already impressive MedTech division.

Now, let's talk numbers. JNJ's current market cap is sitting pretty at just under $400 billion. Sure, it's not in Lilly's $850 billion stratosphere, but remember – slow and steady wins the race.

And speaking of winning races, JNJ was the global leader in pharmaceutical sales last year, raking in $85 billion. That's a cool 30% higher than their closest competitor, Roche (RHHBY).

But here's where it gets interesting for value hunters. JNJ's currently trading at an enterprise value of 12.8 times forward EBITDA. In English? It's reasonably priced compared to its peers.

Even better, it's trading near the bottom of its five-year range for forward P/E ratio, EV-to-EBITDA, and price-to-free cash flow. Translation: This stock's on sale, folks.

Now, I know what some of you are thinking. "But what about those talcum powder lawsuits?" Fair question.

JNJ's looking at potentially settling around $6.5 billion worth of claims. That's not a small amount, even for these guys.

But here's the kicker – they've got over $25 billion in cash on hand and generated about $19 billion in free cash flow over the last 12 months. They can take the hit and keep on ticking.

Let's talk products. Stelara, Tremfya, Darzalex, Erleada – these aren't just random drug names. They're cash cows for JNJ. And with a diverse portfolio where no single drug accounts for more than 13% of total sales, they're not putting all their eggs in one basket.

Still, I'm not saying JNJ is going to double overnight. This isn't some flashy tech stock riding the AI hype wave.

But for those of us with a long-term horizon and a love for steady income, JNJ looks mighty attractive.

Think about it – they've raised their dividend for over six decades straight. That's longer than some of you reading this have been alive.

And with a 77% payout ratio, they've got room to keep that streak going.

Sure, over the past decade, JNJ's total return of 106% might not set your hair on fire. It lags behind the S&P 500's 234% and even the Health Care Select Sector SPDR Fund ETF's (XLV) 189%.

But remember, past performance doesn't always guarantee future results.

Here's my take: JNJ isn't for the get-rich-quick crowd. It's for investors who appreciate a good night's sleep knowing their money's in a company that's weathered world wars, depressions, and yes, even lawsuits.

Will JNJ hit that trillion-dollar mark? I'd bet my last bottle of Tylenol on it. It might take a decade, but hey, good things come to those who wait.

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-08-27 12:00:502024-08-27 12:41:54Not All That Glitters Is Lily
april@madhedgefundtrader.com

August 27, 2024

Diary, Newsletter, Summary

Global Market Comments
August 27, 2024
Fiat Lux

 

Featured Trade:

(WHY YOU MUST AVOID ALL EV PLAYS EXCEPT TESLA),
(TSLA), (GM), (F), (RIVN), (NKLA),
(F-SRNQ)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2024-08-27 09:04:102024-08-27 10:15:23August 27, 2024
Mad Hedge Fund Trader

Why You Must Avoid All EV Plays Except Tesla

Diary, Newsletter, Research

Markets live on fads.

Once a certain investment theme takes hold, the imitators start coming out of the woodwork in droves.

In 1989, all of the largest Japanese banks stampeded issuing naked short put options on the Nikkei Average by the billions of dollars when the index was at an all-time high. The Nikkei then fell by 85% causing tens of billions worth of losses.

I remember signing the paperwork on a $3 billion deal for the Industrial Bank of Japan on behalf of Morgan Stanley. It’s been 35 years, and I’m still waiting for those investors to come after me.

Then there was the peak of the Dotcom Bubble in 2000 and no less than five online pet food delivery companies raised billions. (remember Webvan and those cute sock puppets?) Every one of them went under.

So, what has been one of the biggest fads of 2024?

That would be electric vehicles.

You no longer have to wear Birkenstocks, grow your hair long, and smoke pot to drive an electric car. They have become a major part of the American economy. According to Adam Jonas at Morgan Stanley, EVs account for 8% of the total car market today and will grow to 10% by 2025 and 25% by 2030.

I have been involved with Tesla (TSLA) since its earliest days way back in 2003. Then it was one rich man’s hobby, with technology that was a reach at best, and unlikely to ever see the light of day as a public company. There it remained for seven years.

Then Tesla brought out the Model S in 2010, which I snapped up as fast as I could, picking up chassis no. 125 at the Fremont factory. My signature is still on the wall there as are those for all of the first 125 buyers. Every time I pick up a new Tesla I check if it is still there.

If the Model S worked it had the potential to be a real car. If it didn’t, I would wind up with $100,000 worth of inert aluminum, steel, silicon, rubber, lithium, and copper with only scrap metal value.

The trials were then only just beginning for Musk. He faced nervous breakdowns, sleeping in factories, and SEC prosecutions. After a decade of abuse, suddenly everything clicked. Total Tesla production is now running at a 1.7 million vehicle annual rate. The shares leaped 180-fold to a split-adjusted $425 from their post-IPO low of $2.40. That move financed a lot of retirements among my readers.

I remember what Steve Jobs once told me; “Like many overnight successes, this one took decades to pull off.”

Suddenly, making electric cars looked easy. Raising money to finance them looked even easier.

The problem is that all the new EV entrants now have a hyper-aggressive Tesla to compete against. Tesla has already locked up long-term supplies of crucial commodities essential for EV production, like copper, lithium, and chromium for stainless steel.

It has a 66% market share. It was a lock on experienced EV engineering talent. It has a near monopoly with a 48,000-strong national charging network which Ford (F) had no choice but to sign up for.

The best competitors can hope for is to peel off experienced employees from Tesla at inflated salaries, and then get sued by Tesla.

Enter the hoards, which I list below, a roll call of the shameless:

Nikola Badger (NKLA) – Has a hydrogen fuel cell power source that hasn’t a hope in hell of ever becoming economic. As I never tire of explaining to investors, while electric power is digital and infinitely scalable, hydrogen is analog and isn’t. Maybe that’s why the stock has been a disaster. Too many unbelievable promises and no actual functioning model. Gravity was their only actual power source. It just announced a recall of its electric trucks because of a coolant leak in the battery that caused fires.

Fisker (F-SRNQ) – If at first, you don’t succeed, why not fail again? This VEHICLE had double the number of parts of a conventional international combustion engine. Its chief claim to fame was that it got a free factory from the government in Joe Biden’s home state and the fact that Justin Bieber drove one. More flailing at the wind. It recently went bankrupt….again.

Aspark Owl – A $3.2 niche supercar with an appeal to maybe three car-collecting Saudi princes.

Bollinger B1 – Is a $125,000 SUV expected from a Michigan startup with only a 200-mile range. Why not pay nearly double the cost of a Tesla Model X and get half the performance?

The Byton M-Byte – Is a $45,000 crossover car from a Chinese start-up. China has actually been building electric cars longer than Tesla, but they have a tendency to break down or catch on fire. Quality and safety problems have until now kept them out of the US, and probably always will.

Genesis Essentia – A Croatian-based start-up with a major investment from South Korea’s Hyundai. It will most likely never get off the drawing board. The last time Croatia built cars was for the Austria-Hungarian Empire during WWI.

Rivian R1T (RIVN) – A start-up with a reasonably priced truck and up to 400 miles of range that will only make it because they have a 100,000-unit order from the largest shareholder, Amazon (AMZN). It’s perfect for local deliveries. The cars are beautiful and there is a two-year waiting list for the $80,000 list price vehicles. (RIVN) is the only alternative EV maker that will probably make it.

By now, virtually every major car manufacturer has or is about to roll out its entry in the electric car race. I list them below, skipping those that are more than two years out over the horizon. Notice the profusion of the letter “e” in the names. In fact, there are an astonishing 527 EVs either on, or about to hit the market.

They include the Porsche Taycan, Audi eTron, Jaguar I-Pace, Austin Mini Electric, Fiat 500e, Kia Niro EV, BMW i3, Chevy Bolt EV, Hyundai Kona Electric, and the Hyundai Ioniq Electric, Ford F-150 Electric, Ford Mustang Mach-E, and Nissan Ariya.

Not one of these comes even close to the price/performance and battery density of the Tesla cars. Tesla is a decade ahead of the competition and is accelerating its lead. At best, they will sell a few electric cars to those who are intensely loyal to their brands and lose money doing it.

In the meantime, Tesla hasn’t been sitting on its hands. Elon Musk plans to bring out a $25,000 model in two years that will bar entry to the field from any other competitor. It has its own $250,000 supercar, the Tesla Plaid, which will go zero to 60 MPH in 1.9 seconds and has a 600-mile range. The Tesla Cyber Truck at $60,000 has the specs to take on the enormous US pickup market. Did I mention that the company is on the verge of developing technology that will improve battery performance by a staggering 20-fold?

So Tesla is branching out to suck up every profit in every branch of the entire global auto industry.

And this is what most traders, especially the short sellers, got wrong about Tesla. The data is worth more than the car. The miles driven provide a springboard from which the company can offer very high value-added and profitable services, like autonomous driving. Not even Alphabet (GOOGL) can replicate this.

When I bought my first Tesla more than a decade ago, I knew I was betting on the company. The big risk was that General Motors (GM) would step in with their own cheap electric car and drive Tesla out of business.

In the end (GM) did that, but too little, too late. Its Chevy Bolt EV didn’t hit the market until the end of 2016. Today it offers a boring design, lacks autonomous driving, possesses only a 259-mile range for $36,620, and is subject to recall, thanks to recurring battery fires (click here for the link).

The quality is, well, Chevy quality. The company has already announced it will discontinue production.

Tesla is approaching 2 million. It’s too late to close the barn door after the horse has “bolted,” as GM is earning. Over the past decade, Tesla shares were up 180 times at the high. GM shares are nearly unchanged during the greatest bull market of all time.

It is competing against Teslas that are 20 years from the future, are fully autonomous, go to street-autonomous driving next year, and upgrade itself once or twice a month.

Make mine Tesla, please, which will soon become the world’s first trillion-dollar car company. Don’t waste your time or money on the others, either as a driver or investor.


 

 

 

 

 

 

I’ll Go with Tesla

https://www.madhedgefundtrader.com/wp-content/uploads/2018/10/New-Tesla.png 455 647 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2024-08-27 09:02:542024-08-27 10:14:59Why You Must Avoid All EV Plays Except Tesla
Page 2 of 16‹1234›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
  • Privacy Policy
  • Disclaimer
  • FAQ
Scroll to top